Literature DB >> 19217443

Repeatability and reproducibility of the hyperinsulinemic-euglycemic clamp and the tracer dilution technique in a controlled inpatient setting.

Duc Son N T Le1, Thomas Brookshire, Jonathan Krakoff, Joy C Bunt.   

Abstract

The objective of the study was to evaluate the reproducibility and repeatability of the combined use of the hyperinsulinemic-euglycemic (H-E) clamp and tracer dilution techniques. Ten nondiabetic men underwent a low-dose (40 mU/[m(2) min]) H-E clamp that was repeated within 3 to 4 days using porcine or human insulin in a double-blinded, randomized, crossover design. Coefficients of variation (CVs) for intraindividual differences and repeatability coefficient were calculated to evaluate reproducibility and repeatability. The Bland and Altman method was used to quantify repeatability. The CVs for intraindividual differences were 5.7% +/- 3.5% for steady-state (SS) insulin; 6.7% +/- 6.2% and 54.2 +/- 38.3% for basal and SS endogenous glucose product (EGP), respectively; and 10.3% +/- 8.5% for total insulin-stimulated glucose disposal (M) values. Basal EGP, SS EGP, and SS glucose and insulin concentrations were similar for the 2 clamps; but glucose infusion rate (P = .02) and M (borderline significant, P = .06) were higher in the first clamp than the second clamp. No significant correlations between mean of differences and average of basal and SS EGP, SS insulin concentration, and M between the 2 clamps were observed. We also found that the different values were less than the repeatability coefficients of these parameters and that the 95% limits of agreement and the interval of repeatability coefficient of these parameters were similar. There were no differences in metabolic responses between clamps when compared by the type of insulin (porcine vs human) infused. Our findings indicate that, although SS EGP has a high CV, the clamp, which measures insulin action (ie, SS insulin, M), and the tracer dilution technique for assessing basal EGP are repeatable and reproducible. Decreased glucose infusion rate and M over a short period in the second clamp may reflect an accumulative effect of continued physical inactivity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19217443      PMCID: PMC2692526          DOI: 10.1016/j.metabol.2008.09.029

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  36 in total

1.  Agreement between methods.

Authors:  Karlijn J van Stralen; Kitty J Jager; Carmine Zoccali; Friedo W Dekker
Journal:  Kidney Int       Date:  2008-07-02       Impact factor: 10.612

2.  Responses to human and porcine insulin in healthy subjects.

Authors:  R J Heine; E A van der Heyden; E A van der Veen
Journal:  Lancet       Date:  1989-10-21       Impact factor: 79.321

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

Review 4.  Obesity and insulin resistance: lessons learned from the Pima Indians.

Authors:  S Lillioja; C Bogardus
Journal:  Diabetes Metab Rev       Date:  1988-08

5.  Differential effects of human and pork insulin-induced hypoglycemia on neuronal functions in humans.

Authors:  W Kern; K Lieb; W Kerner; J Born; H L Fehm
Journal:  Diabetes       Date:  1990-09       Impact factor: 9.461

6.  Catecholamine response during human and pork insulin-induced hypoglycemia in IDDM patients.

Authors:  T Lingenfelser; W Renn; C Plonz; M Radjaipour; M Eggstein; B Jakober
Journal:  Diabetes Care       Date:  1992-02       Impact factor: 19.112

7.  Comparison of porcine and semisynthetic human insulins using euglycemic clamp-derived glucose-insulin dose-response curves in insulin-dependent diabetes.

Authors:  M Staten; B Worcester; A Szekeres; N Waldeck; M Ascher; K M Walsh; R Rizza; J Gerich; M A Charles
Journal:  Metabolism       Date:  1984-02       Impact factor: 8.694

8.  The therapeutic efficacy of human insulin (recombinant DNA) in patients with insulin-dependent diabetes mellitus: a comparative study with purified porcine insulin.

Authors:  D C Howey; S E Fineberg; P A Nolen; M I Stone; R G Gibson; N S Fineberg; J A Galloway
Journal:  Diabetes Care       Date:  1982 Nov-Dec       Impact factor: 19.112

9.  Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates.

Authors:  D T Finegood; R N Bergman; M Vranic
Journal:  Diabetes       Date:  1987-08       Impact factor: 9.461

10.  Pathogenesis of NIDDM in Pima Indians.

Authors:  C Bogardus; S Lillioja; P H Bennett
Journal:  Diabetes Care       Date:  1991-07       Impact factor: 19.112

View more
  7 in total

1.  Multi-year reproducibility of hyperinsulinemic euglycemic clamp-derived insulin sensitivity in free-living adults: Association with incident prediabetes in the POP-ABC study.

Authors:  Deirdre James; Nkiru Umekwe; Chimaroke Edeoga; Ebenezer Nyenwe; Sam Dagogo-Jack
Journal:  Metabolism       Date:  2020-05-20       Impact factor: 8.694

Review 2.  Insulin resistance in Alzheimer's disease.

Authors:  Thomas Diehl; Roger Mullins; Dimitrios Kapogiannis
Journal:  Transl Res       Date:  2016-12-13       Impact factor: 7.012

3.  Precision and accuracy of hyperglycemic clamps in a multicenter study.

Authors:  Kieren J Mather; Ashley H Tjaden; Adam Hoehn; Kristen J Nadeau; Thomas A Buchanan; Steven E Kahn; Silva A Arslanian; Sonia Caprio; Karen M Atkinson; Melanie Cree-Green; Kristina M Utzschneider; Sharon L Edelstein
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-03-01       Impact factor: 4.310

4.  Evaluation of surrogate measures of insulin sensitivity - correlation with gold standard is not enough.

Authors:  Anna Rudvik; Marianne Månsson
Journal:  BMC Med Res Methodol       Date:  2018-06-26       Impact factor: 4.615

5.  Nicotinic Acid Accelerates HDL Cholesteryl Ester Turnover in Obese Insulin-Resistant Dogs.

Authors:  Jérôme Le Bloc'h; Véronique Leray; Hassan Nazih; Olivier Gauthier; Samuel Serisier; Thierry Magot; Michel Krempf; Patrick Nguyen; Khadija Ouguerram
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

6.  Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease.

Authors:  Roger J Mullins; Thomas C Diehl; Chee W Chia; Dimitrios Kapogiannis
Journal:  Front Aging Neurosci       Date:  2017-05-03       Impact factor: 5.750

7.  Carnitine supplementation improves metabolic flexibility and skeletal muscle acetylcarnitine formation in volunteers with impaired glucose tolerance: A randomised controlled trial.

Authors:  Yvonne Mh Bruls; Marlies de Ligt; Lucas Lindeboom; Esther Phielix; Bas Havekes; Gert Schaart; Esther Kornips; Joachim E Wildberger; Matthijs Kc Hesselink; Deborah Muoio; Patrick Schrauwen; Vera B Schrauwen-Hinderling
Journal:  EBioMedicine       Date:  2019-10-31       Impact factor: 8.143

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.